A phase I dose-escalation study of a first-in-class HIF1 and HIF2 dual inhibitor R01 in patients with advanced tumors. A novel co-culture system to validate results of a phase I trial testing new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback